Epax AS, Oslo, Norway, has appointed Ola Snøve as CEO, replacing Terje Bakken. Mr. Snøve previously served as an investment director at Aker ASA. He is a member of Epax’s board of directors and knows the company well. Mr. Snøve has conducted postdoctoral research at NTNU’s Department of Cancer Research and Molecular Biology and City of Hope’s Beckman Research Institute in California.